MicroRNAs make for safer cancer treatments
Viruses -- long regarded solely as disease agents -- now are being used in therapies for cancer. Concerns over the safety of these so-called oncolytic viruses stem from their potential to damage healthy tissues. Now Mayo Clinic researchers have discovered a way of controlling the viruses behind potential cancer therapeutics. They are engineering the virus's genetic sequence, using microRNAs to restrict them to specific tissues. The microRNAs destabilize the virus's genome, making it impossible for the virus to run amok. The discovery is reported in the current issue of Nature Medicine. "Our findings demonstrate a new tool for molecular medicine that should also help allay concern over the use of viruses as a therapeutic delivery system," says Stephen Russell, M.D., Ph.D., Mayo physician-scientist and lead author of the study.
MicroRNAs are the nucleotide snippets that are encoded by genes, but don't end up as proteins. In many cases, they have a role in down-regulating different cellular genes. In this case, a virus is engineered to be responsive to microRNAs that are present in certain cell types. Using this new form of targeting, researchers redirected a virus normally responsible for a lethal muscle infection to recognize only cancer cells. The laboratory mice that received the engineered virus were cured of established tumors and suffered no ill effects.
Significance of the research
Most viruses can infect different cell types, which leads to the array of symptoms during a viral infection. Now as viruses are being engineered for use as vaccines, cancer therapeutics and gene therapy vectors, researchers want to restrict and redirect the types of cells they do (or don't) infect as additional safeguards against disease. The target sequences of microRNAs used in the study kept the virus from destroying muscle cells while allowing viral replication to proceed in cancer cells allowing the virus to completely cure mice with melanoma.
The Mayo researchers say microRNA target insertion may be a new way to make viruses safer for use in cancer therapy and could lead to new methods of making safer vaccines.
Source: Mayo Clinic
- Oncolytic viruses mediating anti-tumor immunity in human cancer patientsTue, 18 May 2010, 14:39:36 EDT
- Combinatorial therapy allows viruses to destroy tumorsThu, 1 Apr 2010, 18:16:47 EDT
- BUSM researchers show an oncolytic virus switches off cancer cell surival signalWed, 1 Dec 2010, 14:39:20 EST
- Researchers find function of proteins that can enhance the progression of viruses and cancer cellsMon, 16 Aug 2010, 10:58:01 EDT
- Shark compound proves potential as drug to treat human viruses, says GUMC researcher Mon, 19 Sep 2011, 16:40:45 EDT
- MicroRNAs make for safer cancer treatmentsfrom Science CentricMon, 27 Oct 2008, 6:28:15 EDT
- MicroRNAs make for safer cancer treatmentsfrom Biology News NetMon, 27 Oct 2008, 0:56:22 EDT
- Your Next Cancer Therapy May Be A Virusfrom Scientific BloggingSun, 26 Oct 2008, 20:21:35 EDT
- MicroRNAs Make For Safer Cancer Treatmentsfrom Science DailySun, 26 Oct 2008, 16:14:13 EDT
- MicroRNAs make for safer cancer treatmentsfrom PhysorgSun, 26 Oct 2008, 15:28:23 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- UC Davis engineers create on-wetting fabric drains sweat
- Not just blowing in the wind: Compressing air for renewable energy storage
- Amazon River exhales virtually all carbon taken up by rain forest
- Protein study suggests drug side effects are inevitable
- Bed sharing leads to fivefold increase in risk of cot death for babies whose parents do not smoke
No popular news yet
No popular news yet
- Stem cell transplant restores memory, learning in mice
- 2 landmark studies report on success of using image-guided brachytherapy to treat cervical cancer
- Researchers discover mushrooms can provide as much vitamin D as supplements
- Cutting back on sleep harms blood vessel function and breathing control
- Study: Low-dose aspirin stymies proliferation of 2 breast cancer lines